14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 NRBO stock ended at $3.78. This is 1.34% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.00% from a day low at $3.60 to a day high of $3.78.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical NeuroBo Pharmaceuticals, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $3.67 $3.78 $3.60 $3.78 22 012
May 02, 2024 $3.67 $3.73 $3.55 $3.73 14 889
May 01, 2024 $3.43 $3.68 $3.35 $3.68 60 008
Apr 30, 2024 $3.37 $3.40 $3.25 $3.25 42 199
Apr 29, 2024 $3.23 $3.23 $3.12 $3.23 12 212
Apr 26, 2024 $3.06 $3.14 $3.01 $3.14 16 901
Apr 25, 2024 $3.05 $3.16 $3.03 $3.06 1 778
Apr 24, 2024 $2.99 $3.50 $2.99 $3.10 39 192
Apr 23, 2024 $3.16 $3.19 $3.00 $3.02 41 907
Apr 22, 2024 $3.26 $3.27 $3.08 $3.12 23 219
Apr 19, 2024 $3.49 $3.49 $3.26 $3.37 20 457
Apr 18, 2024 $3.59 $3.59 $3.35 $3.44 22 648
Apr 17, 2024 $3.69 $3.69 $3.46 $3.46 11 420
Apr 16, 2024 $3.62 $3.62 $3.33 $3.40 12 910
Apr 15, 2024 $3.61 $3.73 $3.49 $3.53 22 867
Apr 12, 2024 $3.58 $3.94 $3.58 $3.61 72 612
Apr 11, 2024 $3.69 $3.69 $3.56 $3.58 14 634
Apr 10, 2024 $3.55 $3.66 $3.50 $3.56 13 047
Apr 09, 2024 $3.93 $3.93 $3.47 $3.53 47 378
Apr 08, 2024 $3.80 $3.97 $3.77 $3.97 12 567
Apr 05, 2024 $3.94 $3.94 $3.75 $3.88 24 222
Apr 04, 2024 $3.90 $4.04 $3.82 $3.89 24 733
Apr 03, 2024 $3.93 $4.07 $3.83 $3.89 13 857
Apr 02, 2024 $4.05 $4.05 $3.86 $3.93 27 715
Apr 01, 2024 $4.12 $4.16 $3.80 $4.06 49 344
Click to get the best stock tips daily for free!

About NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify ... NRBO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT